Hofseth Biocare ASA, commonly referred to as Hofseth Biocare, is a leading player in the biotechnology and health supplement industry, headquartered in Norway. Founded in 2009, the company has established itself as a pioneer in the development of high-quality marine ingredients, focusing on sustainable practices and innovative extraction methods. With operations primarily in Norway and a growing presence in international markets, Hofseth Biocare offers a range of unique products, including omega-3 fatty acids, collagen peptides, and other bioactive compounds derived from fish. Their commitment to sustainability and quality has positioned them as a trusted supplier in the health and wellness sector, earning recognition for their advanced research and development initiatives. As a result, Hofseth Biocare continues to make significant strides in promoting health through marine biotechnology.
How does Hofseth Biocare's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Hofseth Biocare's score of 46 is higher than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Hofseth Biocare reported total carbon emissions of approximately 9,653,000 kg CO2e. This figure includes 1,850,000 kg CO2e from Scope 1 emissions, which are direct emissions from owned or controlled sources, and 46,000 kg CO2e from Scope 2 emissions, representing indirect emissions from the generation of purchased electricity. The majority of their emissions, about 7,757,000 kg CO2e, fall under Scope 3, which includes emissions from the entire value chain, such as business travel and transportation. Comparatively, in 2022, Hofseth Biocare's total emissions were about 9,649,000 kg CO2e, with Scope 1 emissions at 2,104,000 kg CO2e and Scope 2 emissions at 47,610 kg CO2e. Scope 3 emissions for that year were approximately 7,498,000 kg CO2e. Despite the significant emissions reported, Hofseth Biocare has not disclosed specific reduction targets or initiatives aimed at decreasing their carbon footprint. The company is based in Norway (NO) and operates globally, indicating a commitment to addressing climate change within the seafood industry. However, further details on their climate commitments or specific reduction strategies are not available.
Access structured emissions data, company-specific emission factors, and source documents
2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|
Scope 1 | 1,619,000 | 0,000,000 | 0,000,000 | 0,000,000 |
Scope 2 | 90,400 | 00,000 | 00,000 | 00,000 |
Scope 3 | - | - | 0,000,000 | 0,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Hofseth Biocare is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.